TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XARELTO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

XARELTO

ST13

US500000078152154

Class

5

Filing

78152154

Registration

2804753

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

12/21/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

08/08/2002

Registration date

01/13/2004

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/01/2024

Last transaction

12/21/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

1

Owner type

09

Owner location

Leverkusen, DE

Examiner

AWRICH, ELLEN

Law office

M70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

B. A. (pessoa física)
B. A. (pessoa física)

Representatives

Phillip Barengolts Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the treatment of [ cancer, ] stroke, [ traumatic brain injury, ] cardiovascular diseases and disorders, [ metabolic diseases and disorders; antibacterial pharmaceuticals, antiviral preparations, ] anticoagulants [ and platelet aggregation inhibitors, ] anti-thrombotic agents [ ; diagnostic preparations and reagents for medical use ]

Publications

History of USPTO decisions and trademark events.

38 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/17/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/17/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/17/2024

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/01/2024

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

05/01/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/01/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/28/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

01/03/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/13/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/16/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/16/2018

NA15

SEC. 15 ACKNOWLEDGEMENT - E-MAILED

12/05/2017

15AK

REGISTERED - SEC. 15 ACKNOWLEDGED

12/05/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/05/2017

E15R

TEAS SECTION 15 RECEIVED

11/17/2017

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/08/2014

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/08/2014

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/08/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/29/2014

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

01/13/2014

E89R

TEAS SECTION 8 & 9 RECEIVED

01/13/2014

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

02/17/2010

PRA8

POST REGISTRATION ACTION MAILED - SEC. 8

01/19/2010

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/13/2010

ES8R

TEAS SECTION 8 RECEIVED

01/12/2010

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/01/2009

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/01/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

01/13/2004

PUBO

PUBLISHED FOR OPPOSITION

10/21/2003

NPUB

NOTICE OF PUBLICATION

10/01/2003

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/18/2003

GNEA

EXAMINERS AMENDMENT E-MAILED

08/18/2003

GNRT

NON-FINAL ACTION E-MAILED

07/28/2003

CFIT

CASE FILE IN TICRS

07/03/2003

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/18/2003

MAIL

PAPER RECEIVED

06/18/2003

GNRT

NON-FINAL ACTION E-MAILED

01/06/2003

DOCK

ASSIGNED TO EXAMINER

01/06/2003

Continuous trademark protection

Get notified about every new filing that threatens XARELTO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.